220 related articles for article (PubMed ID: 7521445)
1. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
[TBL] [Abstract][Full Text] [Related]
2. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
3. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Wakeman JA; Walsh J; Andrews PW
Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins (BMPs) induce epithelial differentiation of NT2D1 human embryonal carcinoma cells.
Caricasole A; Ward-van Oostwaard D; Zeinstra L; van den Eijnden-van Raaij A; Mummery C
Int J Dev Biol; 2000 Aug; 44(5):443-50. PubMed ID: 11032177
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
Damjanov I; Horvat B; Gibas Z
Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
[TBL] [Abstract][Full Text] [Related]
6. Cartilage-derived morphogenetic proteins enhance the osteogenic protein-1-induced osteoblastic cell differentiation of C2C12 cells.
Yeh LC; Tsai AD; Zavala MC; Lee JC
J Cell Physiol; 2004 Dec; 201(3):401-8. PubMed ID: 15389555
[TBL] [Abstract][Full Text] [Related]
7. Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro.
Knutsen R; Wergedal JE; Sampath TK; Baylink DJ; Mohan S
Biochem Biophys Res Commun; 1993 Aug; 194(3):1352-8. PubMed ID: 8352794
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts.
Zhou H; Hammonds RG; Findlay DM; Martin TJ; Ng KW
J Cell Physiol; 1993 Apr; 155(1):112-9. PubMed ID: 8385674
[TBL] [Abstract][Full Text] [Related]
9. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
10. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
11. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bone morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner.
Erickson DM; Harris SE; Dean DD; Harris MA; Wozney JM; Boyan BD; Schwartz Z
J Orthop Res; 1997 May; 15(3):371-80. PubMed ID: 9246083
[TBL] [Abstract][Full Text] [Related]
13. Osteogenic protein-1, a bone morphogenic protein member of the TGF-beta superfamily, shares chemotactic but not fibrogenic properties with TGF-beta.
Postlethwaite AE; Raghow R; Stricklin G; Ballou L; Sampath TK
J Cell Physiol; 1994 Dec; 161(3):562-70. PubMed ID: 7962137
[TBL] [Abstract][Full Text] [Related]
14. Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells.
Piek E; Afrakhte M; Sampath K; van Zoelen EJ; Heldin CH; ten Dijke P
J Cell Physiol; 1999 Aug; 180(2):141-9. PubMed ID: 10395283
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
16. Number of adrenergic and islet-1 immunoreactive cells is increased in avian trunk neural crest cultures in the presence of human recombinant osteogenic protein-1.
Varley JE; Wehby RG; Rueger DC; Maxwell GD
Dev Dyn; 1995 Aug; 203(4):434-47. PubMed ID: 7496035
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts.
Benayahu D; Fried A; Shamay A; Cunningham N; Blumberg S; Wientroub S
J Cell Biochem; 1994 Sep; 56(1):62-73. PubMed ID: 7528753
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
Pera MF; Bennett W; Cerretti DP
Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
[TBL] [Abstract][Full Text] [Related]
19. Opposite effects of osteogenic protein and transforming growth factor beta on chondrogenesis in cultured long bone rudiments.
Dieudonné SC; Semeins CM; Goei SW; Vukicevic S; Nulend JK; Sampath TK; Helder M; Burger EH
J Bone Miner Res; 1994 Jun; 9(6):771-80. PubMed ID: 8079653
[TBL] [Abstract][Full Text] [Related]
20. Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 or BMP4.
Glozak MA; Rogers MB
Dev Biol; 1996 Nov; 179(2):458-70. PubMed ID: 8903360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
